Seqirus (or equal) seasonal influenza vaccine doses to FDA Occupational Health Units (OHUs) at the White Oak Campus in Silver Spring, MD, and the Jefferson Laboratories Campus in Jefferson, AR

The FDA Office of Acquisition and Grant Services is seeking potential vendors to supply seasonal influenza vaccines for the 2025-2026 influenza season to support FDA Occupational Health Units at two campus locations. The procurement specifically requires 4,100 total vaccine units, with 4,000 doses for adults under 65 years and 100 doses for adults 65 and older, requesting Seqirus FLUAD TIV 0.5mL Prefilled Syringe for the older demographic and Flucelvax TIV 0.5mL Prefilled Syringe or equivalent FDA-approved products for the younger group. Vendors must demonstrate capability to deliver vaccines to the White Oak Campus in Silver Spring, MD, and the Jefferson Laboratories Campus in Jefferson, AR, with a critical delivery deadline of October 1, 2025. Interested parties must submit capability statements by email to suzanne.martella@fda.hhs.gov by 3:00pm Central Time on July 10, 2025, referencing solicitation number 75F40125SSNFLUVAX. The evaluation will focus on company information, past performance, technical capabilities, and manufacturing location details.

This procurement does not utilize any set-aside designations, though the notice specifically targets small businesses under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) with a size standard of 1,300 employees, while allowing all interested parties to respond. The contract requires delivery of 3,900 vaccine units to the White Oak Campus in Silver Spring, MD, and 200 units to the Jefferson Laboratories Campus in Jefferson, AR, totaling 4,100 doses across both locations. No incumbent contractors or current service providers are identified in the sources sought notice. The procurement timeline is compressed, with responses due within eight days of the notice posting and delivery required before October 1, 2025, indicating an urgent need for vaccine supply ahead of the upcoming flu season. No specific contract values or budget ranges are disclosed in the pre-solicitation documentation.